30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

LENZ Therapeutics Inc (LENZ)

Track

Over the last 90 days, insider trading at LENZ Therapeutics Inc. shows a net buy of $365,575. Notably, three executives made purchases totaling $315,685. The company's stock has experienced a significant decline of 43.4% over the past 90 days, trading near its 52-week low.
Stock chart
Ticker: LENZ Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
George Jeffrey P.
1 purchase — total 49,890 USD
Buy 27 Mar 2026
Value US$1,843,122.30 | Price 413.96 | Shares 32,450
Buy 27 Mar 2026
Value US$3,299,856.35 | Price 194.68 | Shares 46,083
Buy 27 Mar 2026
Value US$251,410.59 | Price 8.95 | Shares 28,089
Planned sale 17 Nov 2025
Value US$152,611.62 | Price 26.37 | Shares 5,788
Planned sale 17 Nov 2025
Value US$108,410.56 | Price 25.74 | Shares 4,212
Proposed sale 17 Nov 2025
Value US$1,024,000.00 | Price 25.60 | Shares 40,000
Buy 7 Nov 2025
Value US$239,278.20 | Price 22.79 | Shares 10,500
Buy 7 Nov 2025
Value US$49,562.79 | Price 22.76 | Shares 2,178
Buy 7 Nov 2025
Value US$454.20 | Price 22.71 | Shares 20
Sale 30 Sep 2025
Value US$5,782.64 | Price 47.01 | Shares 123
Sale 30 Sep 2025
Value US$8,321.35 | Price 47.01 | Shares 177
Sale 30 Sep 2025
Value US$2,668,483.81 | Price 46.41 | Shares 57,502
Sale 30 Sep 2025
Value US$3,854,827.25 | Price 46.41 | Shares 83,066
Sale 30 Sep 2025
Value US$1,560,428.45 | Price 45.35 | Shares 34,405
Sale 30 Sep 2025
Value US$2,254,173.94 | Price 45.35 | Shares 49,701
Sale 18 Sep 2025
Value US$5,715.60 | Price 43.30 | Shares 132
Sale 18 Sep 2025
Value US$11,604.40 | Price 43.30 | Shares 268
Sale 18 Sep 2025
Value US$866,440.56 | Price 43.00 | Shares 20,148
Sale 18 Sep 2025
Value US$1,759,156.45 | Price 43.00 | Shares 40,907
Sale 18 Sep 2025
Value US$1,013,567.80 | Price 41.59 | Shares 24,370
Sale 18 Sep 2025
Value US$2,057,871.19 | Price 41.59 | Shares 49,479
Sale 26 Aug 2025
Value US$67,430.26 | Price 39.50 | Shares 1,707
Sale 26 Aug 2025
Value US$136,875.12 | Price 39.50 | Shares 3,465
Sale 26 Aug 2025
Value US$844,224.48 | Price 38.97 | Shares 21,661
Sale 26 Aug 2025
Value US$1,714,016.16 | Price 38.97 | Shares 43,978
Sale 25 Aug 2025
Value US$42,236.63 | Price 39.92 | Shares 1,058
Sale 25 Aug 2025
Value US$85,790.66 | Price 39.92 | Shares 2,149
Sale 25 Aug 2025
Value US$978,651.38 | Price 39.53 | Shares 24,760
Sale 25 Aug 2025
Value US$1,986,946.88 | Price 39.53 | Shares 50,270
Sale 22 Aug 2025
Value US$114,017.03 | Price 40.59 | Shares 2,809
Sale 22 Aug 2025
Value US$230,063.55 | Price 40.59 | Shares 5,668
Sale 22 Aug 2025
Value US$403,339.26 | Price 40.03 | Shares 10,076
Sale 22 Aug 2025
Value US$820,328.64 | Price 40.03 | Shares 20,493
Sale 18 Aug 2025
Value US$581,694.19 | Price 38.56 | Shares 15,085
Sale 18 Aug 2025
Value US$1,181,049.37 | Price 38.56 | Shares 30,628
Sale 15 Aug 2025
Value US$2,762,985.50 | Price 39.50 | Shares 69,949
Sale 15 Aug 2025
Value US$5,729,514.50 | Price 39.50 | Shares 145,051
Sale 10 Jul 2025
Value US$6,506,784.00 | Price 34.00 | Shares 191,376
Sale 27 Jun 2025
Value US$6,093,000.00 | Price 30.47 | Shares 200,000
Sale 20 Jun 2025
Value US$4,051,201.00 | Price 30.25 | Shares 133,924
Sale 20 Jun 2025
Value US$3,061,616.95 | Price 30.35 | Shares 100,877
Sale 18 Jun 2025
Value US$2,995,000.00 | Price 29.95 | Shares 100,000
Sale 10 Jun 2025
Value US$10,150,000.00 | Price 29.00 | Shares 350,000
Buy 14 May 2024
Value US$49,987.84 | Price 15.68 | Shares 3,188
Buy 14 May 2024
Value US$49,987.84 | Price 15.68 | Shares 3,188
Buy 13 May 2024
Value US$501,092.68 | Price 15.99 | Shares 31,332
Buy 21 Mar 2024
Value US$976,514.13 | Price 15.03 | Shares 64,971
Buy 21 Mar 2024
Value US$14,023,561.14 | Price 15.03 | Shares 933,038
Buy 12 Apr 2022
Value US$1,428,000.00 | Price 4.08 | Shares 350,000
Planned buy 11 Apr 2022
Value US$20,050.00 | Price 4.01 | Shares 5,000
Buy 11 Apr 2022
Value US$303,068.48 | Price 4.07 | Shares 74,464
Buy 24 Jan 2022
Value US$200,100.00 | Price 8.70 | Shares 23,000
Buy 21 Jan 2022
Value US$899,000.00 | Price 8.99 | Shares 100,000
Buy 20 Jan 2022
Value US$384,496.60 | Price 8.92 | Shares 43,105
Buy 19 Jan 2022
Value US$504,180.60 | Price 9.24 | Shares 54,565
Buy 15 Dec 2021
Value US$227,532.51 | Price 10.19 | Shares 22,329
Buy 22 Nov 2021
Value US$2,047,102.75 | Price 10.15 | Shares 201,685
Buy 15 Oct 2021
Value US$28,727.00 | Price 12.49 | Shares 2,300
Buy 14 Oct 2021
Value US$38,750.00 | Price 12.50 | Shares 3,100
Buy 13 Oct 2021
Value US$600,188.00 | Price 13.22 | Shares 45,400
Buy 8 Oct 2021
Value US$984,000.00 | Price 13.12 | Shares 75,000
Buy 7 Oct 2021
Value US$134,773.74 | Price 14.94 | Shares 9,021
Buy 6 Oct 2021
Value US$850,199.25 | Price 13.83 | Shares 61,475
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-27 B Purchase
2.4
George Jeffrey P.
Non-Executive Director
32,450 -28.5%
413.96
US$1,843,122 		32,450 -28.5% 413.96 US$1,843,122
2026-03-30 2026-03-27 B Purchase
3.4
Chevallard Daniel R.

Chief Financial Officer

Officer
46,083 -1.8%
194.68
US$3,299,856 		46,083 -1.8% 194.68 US$3,299,856
2026-03-30 2026-03-27 B Purchase
Schimmelpennink Evert B.

President, CEO and Secretary

Executive Director
20,141 -36.0%
470.55
US$4,713,244 		20,141 -36.0% 470.55 US$4,713,244
2025-11-19 2025-11-17 PlS Planned sale
Olsson Shawn

Chief Commercial Officer

Officer
5,788 -55.0%
26.37
US$152,612 		5,788 -55.0% 26.37 US$152,612
2025-11-19 2025-11-17 PlS Planned sale
Olsson Shawn

Chief Commercial Officer

Officer
4,212 -28.6%
25.74
US$108,411 		4,212 -28.6% 25.74 US$108,411
2025-11-17 2025-11-17 PrS Proposed sale
SHAWN OLSSON

Officer

Officer
40,000
25.60
US$1,024,000 		40,000 25.60 US$1,024,000
2025-11-10 2025-11-07 B Purchase
3.4
MCCOLLUM JAMES W
Non-Executive Director
10,500 +inf%
22.79
US$239,278 		10,500 +inf% 22.79 US$239,278
2025-11-07 2025-11-07 B Purchase
3.4
Chevallard Daniel R.

Chief Financial Officer

Officer
2,178 +67.9%
22.76
US$49,563 		2,178 +67.9% 22.76 US$49,563
2025-11-07 2025-11-07 B Purchase
3.4
Chevallard Daniel R.

Chief Financial Officer

Officer
20 +0.6%
22.71
US$454 		20 +0.6% 22.71 US$454
2025-10-02 2025-09-30 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
123 -0.0%
47.01
US$5,783 		123 -0.0% 47.01 US$5,783
2025-10-02 2025-09-30 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
177 -0.0%
47.01
US$8,321 		177 -0.0% 47.01 US$8,321
2025-10-02 2025-09-30 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
57,502 -7.0%
46.41
US$2,668,484 		57,502 -7.0% 46.41 US$2,668,484
2025-10-02 2025-09-30 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
83,066 -7.3%
46.41
US$3,854,827 		83,066 -7.3% 46.41 US$3,854,827
2025-10-02 2025-09-30 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
34,405 -4.0%
45.35
US$1,560,428 		34,405 -4.0% 45.35 US$1,560,428
2025-10-02 2025-09-30 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
49,701 -4.2%
45.35
US$2,254,174 		49,701 -4.2% 45.35 US$2,254,174
2025-09-22 2025-09-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
132 -0.0%
43.30
US$5,716 		132 -0.0% 43.30 US$5,716
2025-09-22 2025-09-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
268 -0.0%
43.30
US$11,604 		268 -0.0% 43.30 US$11,604
2025-09-22 2025-09-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
20,148 -2.3%
43.00
US$866,441 		20,148 -2.3% 43.00 US$866,441
2025-09-22 2025-09-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
40,907 -3.3%
43.00
US$1,759,156 		40,907 -3.3% 43.00 US$1,759,156
2025-09-22 2025-09-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
24,370 -2.7%
41.59
US$1,013,568 		24,370 -2.7% 41.59 US$1,013,568
2025-09-22 2025-09-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
49,479 -3.9%
41.59
US$2,057,871 		49,479 -3.9% 41.59 US$2,057,871
2025-08-26 2025-08-26 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
1,707 -0.2%
39.50
US$67,430 		1,707 -0.2% 39.50 US$67,430
2025-08-26 2025-08-26 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
3,465 -0.3%
39.50
US$136,875 		3,465 -0.3% 39.50 US$136,875
2025-08-26 2025-08-26 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
21,661 -2.3%
38.97
US$844,224 		21,661 -2.3% 38.97 US$844,224
2025-08-26 2025-08-26 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
43,978 -3.3%
38.97
US$1,714,016 		43,978 -3.3% 38.97 US$1,714,016
2025-08-26 2025-08-25 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
1,058 -0.1%
39.92
US$42,237 		1,058 -0.1% 39.92 US$42,237
2025-08-26 2025-08-25 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
2,149 -0.2%
39.92
US$85,791 		2,149 -0.2% 39.92 US$85,791
2025-08-26 2025-08-25 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
24,760 -2.6%
39.53
US$978,651 		24,760 -2.6% 39.53 US$978,651
2025-08-26 2025-08-25 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
50,270 -3.7%
39.53
US$1,986,947 		50,270 -3.7% 39.53 US$1,986,947
2025-08-26 2025-08-22 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
2,809 -0.3%
40.59
US$114,017 		2,809 -0.3% 40.59 US$114,017
2025-08-26 2025-08-22 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
5,668 -0.4%
40.59
US$230,064 		5,668 -0.4% 40.59 US$230,064
2025-08-26 2025-08-22 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
10,076 -1.0%
40.03
US$403,339 		10,076 -1.0% 40.03 US$403,339
2025-08-26 2025-08-22 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
20,493 -1.5%
40.03
US$820,329 		20,493 -1.5% 40.03 US$820,329
2025-08-19 2025-08-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
15,085 -1.5%
38.56
US$581,694 		15,085 -1.5% 38.56 US$581,694
2025-08-19 2025-08-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
30,628 -2.1%
38.56
US$1,181,049 		30,628 -2.1% 38.56 US$1,181,049
2025-08-19 2025-08-15 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
69,949 -6.7%
39.50
US$2,762,986 		69,949 -6.7% 39.50 US$2,762,986
2025-08-19 2025-08-15 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
145,051 -9.2%
39.50
US$5,729,514 		145,051 -9.2% 39.50 US$5,729,514
2025-07-14 2025-07-10 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
191,376 -10.8%
34.00
US$6,506,784 		191,376 -10.8% 34.00 US$6,506,784
2025-07-01 2025-06-27 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
200,000 -10.2%
30.47
US$6,093,000 		200,000 -10.2% 30.47 US$6,093,000
2025-06-20 2025-06-20 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
133,924 -6.4%
30.25
US$4,051,201 		133,924 -6.4% 30.25 US$4,051,201
2025-06-20 2025-06-20 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
100,877 -8.8%
30.35
US$3,061,617 		100,877 -8.8% 30.35 US$3,061,617
2025-06-20 2025-06-18 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
100,000 -8.0%
29.95
US$2,995,000 		100,000 -8.0% 29.95 US$2,995,000
2025-06-12 2025-06-10 S Sale
3.3
Versant Venture Capital VI, L.P.
Large shareholder
350,000 -21.9%
29.00
US$10,150,000 		350,000 -21.9% 29.00 US$10,150,000
2024-05-15 2024-05-14 B Purchase
3.4
Chevallard Daniel R.

Chief Financial Officer

Officer
3,188 +inf%
15.68
US$49,988 		3,188 +inf% 15.68 US$49,988
2024-05-15 2024-05-14 B Purchase
3.4
Chevallard Daniel R.

Chief Financial Officer

Officer
3,188 +inf%
15.68
US$49,988 		3,188 +inf% 15.68 US$49,988
2024-05-14 2024-05-13 B Purchase
3.4
MCCOLLUM JAMES W
Non-Executive Director
31,332 +6.3%
15.99
US$501,093 		31,332 +6.3% 15.99 US$501,093
2024-03-25 2024-03-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
64,971 +10.3%
15.03
US$976,514 		64,971 +10.3% 15.03 US$976,514
2024-03-25 2024-03-21 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
933,038 +39.1%
15.03
US$14,023,561 		933,038 +39.1% 15.03 US$14,023,561
2022-04-13 2022-04-12 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
350,000 +4.3%
4.08
US$1,428,000 		350,000 +4.3% 4.08 US$1,428,000
2022-04-13 2022-04-11 PP Planned purchase
Gutry Phil

CHIEF BUSINESS OFFICER

Officer
5,000 +1.7%
4.01
US$20,050 		5,000 +1.7% 4.01 US$20,050
2022-04-13 2022-04-11 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
74,464 +0.9%
4.07
US$303,068 		74,464 +0.9% 4.07 US$303,068
2022-01-25 2022-01-24 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
23,000 +0.3%
8.70
US$200,100 		23,000 +0.3% 8.70 US$200,100
2022-01-25 2022-01-21 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
100,000 +1.3%
8.99
US$899,000 		100,000 +1.3% 8.99 US$899,000
2022-01-21 2022-01-20 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
43,105 +0.5%
8.92
US$384,497 		43,105 +0.5% 8.92 US$384,497
2022-01-21 2022-01-19 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
54,565 +0.7%
9.24
US$504,181 		54,565 +0.7% 9.24 US$504,181
2021-12-20 2021-12-15 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
22,329 +0.3%
10.19
US$227,533 		22,329 +0.3% 10.19 US$227,533
2021-11-24 2021-11-22 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
201,685 +2.7%
10.15
US$2,047,103 		201,685 +2.7% 10.15 US$2,047,103
2021-10-15 2021-10-15 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
2,300 +0.0%
12.49
US$28,727 		2,300 +0.0% 12.49 US$28,727
2021-10-15 2021-10-14 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
3,100 +0.0%
12.50
US$38,750 		3,100 +0.0% 12.50 US$38,750
2021-10-15 2021-10-13 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
45,400 +0.6%
13.22
US$600,188 		45,400 +0.6% 13.22 US$600,188
2021-10-08 2021-10-08 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
75,000 +1.0%
13.12
US$984,000 		75,000 +1.0% 13.12 US$984,000
2021-10-08 2021-10-07 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
9,021 +0.1%
14.94
US$134,774 		9,021 +0.1% 14.94 US$134,774
2021-10-08 2021-10-06 B Purchase
1.7
Samsara BioCapital, L.P.
Large shareholder
61,475 +0.8%
13.83
US$850,199 		61,475 +0.8% 13.83 US$850,199
Explore more

More insider trading research around LENZ Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America